Publication | Open Access

Synthesis, pharmacological and in silico evaluation of 1-(4-di-hydroxy-3,5-dioxa-4-borabicyclo[4.4.0]deca-7,9,11-trien-9-yl)-2-(tert-butylamino)ethanol, a compound designed to act as a β2 adrenoceptor agonist

Molecular PharmacologySilico EvaluationPharmacological StudyBiochemistryMedicineMechanism Of ActionPharmacological AgentExperimental PharmacologyPharmacotherapyβ2 Adrenoceptor AgonistPharmacologyPharmaceutical ChemistryDrug Discovery